Traws PharmaTRAW
13F holders, Q3 2025 (September 30)18holders −1
3new positions
4sold out
$1.85avg. 13F price*
At the end of Q3 2025, 18 institutions reported holding Traws Pharma Inc. (TRAW) in their 13F filings, down 1 from Q2 2025. 3 opened new positions and 4 sold out. The largest holders were Orbimed Advisors LLC ($1.1M), Adage Capital Partners Gp, L.L.C. ($611K) and Vestal Point Capital, LP ($278K).
- Company
- Traws Pharma Inc.
- CUSIP
- 68232V884
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $43K |
| Exits | 4 | $104K |
All 13F filers, Q2 2025 → Q3 2025: 114,715 shares bought and 73,607 shares sold, net +41,108 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Orbimed Advisors LLC | 0.03% | No change | 605,531 | $1.1M |
| Adage Capital Partners Gp, L.L.C. | 0.00% | No change | 330,000 | $611K |
| Vestal Point Capital, LP | 0.01% | Add +0.1% | 150,000 | $278K |
| Vanguard Group Inc. | 0.00% | Add +562.4% | 87,259 | $161K |
| Geode Capital Management, LLC | 0.00% | Add +21.6% | 43,440 | $80K |
| Ikarian Capital, LLC | 0.01% | No change | 28,493 | $53K |
| Two Sigma Investments, LP | 0.00% | Add +37.1% | 22,018 | $41K |
| HRT Financial LP | 0.00% | New | 12,573 | $23K |
| XTX Topco Ltd | 0.00% | New | 10,708 | $20K |
| BlackRock, Inc. | 0.00% | No change | 9,956 | $18K |
| Citigroup Inc. | 0.00% | Add +5780.0% | 3,528 | $7K |
| Morgan Stanley | 0.00% | No change | 719 | $1K |
| SBI Securities Co., Ltd. | 0.00% | No change | 162 | $300 |
| Bank of America Corp. | 0.00% | Add +8.5% | 102 | $189 |
| Vermillion & White Wealth Management Group, LLC | 0.00% | No change | 96 | $178 |
| UBS Group AG | 0.00% | Reduce -99.8% | 6 | $11 |
| FMR LLC | 0.00% | No change | 2 | $4 |
| Assetmark, Inc. | 0.00% | New | 2 | $4 |
"% of holder's portfolio" is TRAW's weight in each manager's 13F, not the share of Traws Pharma Inc. the manager owns.